subependymal giant cell astrocytoma
Information
- Disease name
- subependymal giant cell astrocytoma
- Disease ID
- DOID:5077
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00411619 | Completed | Phase 1/Phase 2 | Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex | January 2007 | January 2014 |
| NCT00789828 | Completed | Phase 3 | Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) | August 2009 | October 2014 |
| NCT02654340 | Terminated | Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) | August 1, 2018 | December 30, 2022 |
- Disase is a (Disease Ontology)
- DOID:4843
- Cross Reference ID (Disease Ontology)
- GARD:10632
- Cross Reference ID (Disease Ontology)
- ICDO:9384/1
- Cross Reference ID (Disease Ontology)
- MESH:D001254
- Cross Reference ID (Disease Ontology)
- NCI:C3696
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:449799008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0205768
- Exact Synonym (Disease Ontology)
- SEGA